Opportunity to Invest in Healthcare/ ESG
We’re keeping tabs on some of the exciting offers coming across our desk and one that we wanted to share with you is Bioactive Laboratories, led by a fantastic team of founders with years of experience who found a significant gap in the market:
45% of reproductive age women suffer severe period pain, needing medication every month – amounting to around 1.17B women globally
To enable thousands of customers to go about their daily activities, Bioactive Laboratories have developed Khapregesic®, a fast-acting non-drug alternative to relieve pain: both period pain and pain from associated conditions (Endometriosis & PCOS), with additional observed benefits: sleep quality improvement, anxiety reduction, and an array of PMS symptoms alleviated. The product has generated hundreds of positive customer reviews.
Clinical evidence and now customer feedback have confirmed many other Khapregesic® applications.
From joint and muscle pain to anxiety, memory and sleep improvement. A complete range has been designed, formulated and is ready to roll-out.
Once the market model of Khapregesic® for Period Pain is established, they can quickly leverage new applications.
Plus, Bioactive Laboratories scientists have discovered an array of other treatments yet to be commercialised. Khapregesic® Pipeline Clinical evidence and now customer feedback have confirmed many other Khapregesic® applications.
Bioactive Laboratories: raising A$2M
- controls the entire supply chain with IP and trade secrets protection;
- clinically tested & regulatory approved;
- 100+ Customers & Resellers, 180k+ Ad reach, 100k+ organic reach per week and growing.
► Register interest in Bioactive Laboratories. Bioactive Laboratories is a carbon positive company, addressing 4 of the UN sustainable development goals: Gender Equality, Biodiversity, Health and Climate Change.
© 2020 KapVista